Evaluation of Pharmacokinetics and Pharmacodynamics of Deferasirox in Pediatric Patients.

The population pharmacokinetic model described the interindividual variability and identified Ctrough threshold values that were predictive of hepatic/renal and hematological toxicities associated with DFX.